Stephen Schultz | Vice President, Investor Relations |
Justin Gover | Chief Executive Officer |
Darren Cline | U.S. Chief Commercial Officer |
Chris Tovey | Chief Operating Officer |
Dr. Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
Tazeen Ahmad | Bank of America |
Salveen Richter | Goldman Sachs |
Phil Nadeau | Cowen and Company |
Josh Schimmer | Evercore ISI |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB Leerink |
Paul Matteis | Stifel |
Serge Belanger | Needham & Company |
Neena Bitritto-Garg | Citi |
David Lebowitz | Morgan Stanley |
Yatin Suneja | Guggenheim Partners |
David Kideckel | ATB Capital Markets |
Daniel Brill | Raymond James |
Francois Brisebois | Oppenheimer |
Douglas Tsao | H.C. Wainwright |
Greetings. And welcome to the GW Pharmaceuticals Third Quarter 2020 Financial Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.